ACUTE MYELOID LEUKEMIA (AML)
Clinical trials for ACUTE MYELOID LEUKEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral drug combo tested for hard-to-treat blood cancer
Disease control Not yet recruitingThis study aims to find a safe and effective dose of an oral drug called cladribine when given with two other leukemia medications. It will test this combination in adults with acute myeloid leukemia (AML) who have either newly diagnosed or relapsed disease. The goal is to see if…
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for blood cancer patients: experimental combo challenges standard chemo
Disease control Not yet recruitingThis study compares two treatment approaches for adults newly diagnosed with acute myeloid leukemia (AML), a serious blood cancer. Researchers want to see if a new combination of three drugs works better and is safer than the current standard chemotherapy. The trial will enroll 2…
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Blood test could be key to picking winning leukemia treatment
Disease control Not yet recruitingThis study is testing whether a new blood test can help doctors choose the most effective chemotherapy for adults newly diagnosed with acute myeloid leukemia (AML). About 112 patients will receive one of two standard chemotherapy types, and the blood test will check for tiny amou…
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Major trial aims to boost remission rates for seniors with aggressive blood cancer
Disease control Not yet recruitingThis large Phase 3 trial will test whether adding a third drug (homoharringtonine) to a standard two-drug leukemia treatment works better for older adults. It will enroll 308 newly diagnosed patients aged 60-75 with acute myeloid leukemia (AML). The main goal is to see if the thr…
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE3 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for tough leukemia cases: trial tests combo to overcome treatment resistance
Disease control Not yet recruitingThis study is testing whether a combination of three drugs—cladribine, low-dose cytarabine, and venetoclax—can help control acute myeloid leukemia (AML) in adults whose cancer has returned or didn't respond to previous treatment containing venetoclax. The goal is to see if this r…
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New immune cell therapy tested for kids with tough leukemia
Disease control Not yet recruitingThis early-stage trial is testing a new type of treatment called CART123 for children and young adults whose acute myeloid leukemia (AML) has come back or hasn't responded to other therapies. The study will see if these specially engineered immune cells are safe and work better w…
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Stanford tests bold move: stop rejection drug early after transplant
Disease control Not yet recruitingThis study aims to see if it's safe and possible to stop a key anti-rejection medication (tacrolimus) much earlier than usual after a bone marrow transplant. It will involve 50 adults with various blood cancers who receive a transplant from a matched donor. The goal is to reduce …
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC
-
Massive data hunt launched to crack code on childhood leukemia
Knowledge-focused Not yet recruitingThis study aims to create a large, unified database by combining existing medical and research data from children and young adults with acute myeloid leukemia (AML) in France. The goal is to find hidden patterns by studying many patients together, which is hard to do for rare dis…
Matched conditions: ACUTE MYELOID LEUKEMIA (AML)
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC